The early development of acute leukaemias is assumed for the most part to be clinically silent and transient. But it now seems that ancestral precancerous cells are identifiable and persistent. See Article p.328
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
Nature Communications Open Access 24 February 2016
-
Evaluation of clonal origin of malignant mesothelioma
Journal of Translational Medicine Open Access 04 December 2014
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Greaves, M. & Maley, C. C. Nature 481, 306–313 (2012).
Shlush, L. I. et al. Nature 506, 328–333 (2014).
Welch, J. S. et al. Cell 150, 264–278 (2012).
Vassiliou, G. S. et al. Nature Genet. 43, 470–475 (2011).
Challen, G. A. et al. Nature Genet. 44, 23–31 (2012).
Ley, T. J. et al. N. Engl. J. Med. 363, 2424–2433 (2010).
Kim, S. J. et al. Blood 122, 4086–4089 (2013).
Miyamoto, T., Weissman, I. L. & Akashi, L. Proc. Natl Acad. Sci. USA 97, 7521–7526 (2000).
Jan, M. et al. Sci. Transl. Med. 4, 149ra118 (2012).
Walter, M. J. et al. N. Engl. J. Med. 366, 1090–1098 (2012).
Papaemmanuil, E. et al. Blood 122, 3616–3627 (2013).
Jamieson, C .H. M. et al. N. Engl. J. Med. 351, 657–667 (2004).
Hong, D. et al. Science 319, 336–339 (2008).
Krönke, J. et al. Blood 122, 100–108 (2013).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Potter, N., Greaves, M. Persistence of leukaemic ancestors. Nature 506, 300–301 (2014). https://doi.org/10.1038/nature13056
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature13056
This article is cited by
-
Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
Molecular Diagnosis & Therapy (2019)
-
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
Nature Communications (2016)
-
Evaluation of clonal origin of malignant mesothelioma
Journal of Translational Medicine (2014)